Welcome to our dedicated page for Inflection Point Acquisition IV SEC filings (Ticker: BACQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Inflection Point Acquisition Corp. IV (BACQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a Nasdaq-listed blank check company. Inflection Point Acquisition Corp. IV, a Cayman Islands exempted company and emerging growth company, files current and periodic reports with the U.S. Securities and Exchange Commission that describe its capital structure, governance and proposed business combination activities.
Among the key documents available are multiple Forms 8-K detailing material events. A filing dated September 23, 2025 describes the Business Combination Agreement between Bleichroeder Acquisition Corp. I (which will be renamed Inflection Point Acquisition Corp. IV), a merger subsidiary and Merlin Labs, Inc., a developer of assured, autonomous flight technology for defense customers. This 8-K also discusses a strategic partnership between Merlin Labs and GE Aerospace and notes that Inflection Point Acquisition Corp. IV and Merlin Labs are contemplating additional private placement financing in connection with the business combination.
An 8-K dated October 21, 2025 reports shareholder approval of changing the company’s name to Inflection Point Acquisition Corp. IV and amending its articles to modify redemption timing for public shares. Another 8-K dated November 17, 2025 outlines amendments to a Securities Purchase Agreement and additional securities purchase agreements that increase PIPE commitments for preferred stock and warrants to be issued by New Merlin Labs in connection with the transaction.
Through this filings page, users can review these 8-Ks, the definitive proxy statement on Schedule 14A regarding the name change and article amendments, and future registration statements on Form S-4 related to the proposed business combination. Stock Titan enhances this access with AI-powered summaries that highlight the main terms of the business combination, changes to shareholder rights, and details of PIPE and pre-funded note financings, helping readers interpret BACQ’s SPAC-related disclosures more efficiently.
Bleichroeder Acquisition Corp. I (BACQ) filed a preliminary proxy describing an Extraordinary General Meeting to vote on a proposed corporate name change, an amendment labeled the Article 50.5 Amendment, and an adjournment proposal. The filing discloses that certain officers resigned in July 2025 and a new management team affiliated with Inflection Point Fund I LP was appointed, and the company proposes to effect a name change in connection with these changes. It details IPO redemption mechanics: a cash per-share Redemption Price equal to the trust account balance (net interest) divided by then-issued public shares calculated two business days before consummation of the Business Combination. The proxy includes meeting logistics, quorum and voting rules, broker non-vote treatment, and standard forward-looking statement cautionary language.